Technosphere® Insulin with MedTone C Inhaler + Technosphere ®Insulin with Gen2 Inhaler + Insulin Aspart in combination with a basal insulin
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 34/100
34
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Type 1 Diabetes Mellitus
Conditions
Type 1 Diabetes Mellitus
Trial Timeline
Sep 1, 2011 → Jun 1, 2013
NCT ID
NCT01445951About Technosphere® Insulin with MedTone C Inhaler + Technosphere ®Insulin with Gen2 Inhaler + Insulin Aspart in combination with a basal insulin
Technosphere® Insulin with MedTone C Inhaler + Technosphere ®Insulin with Gen2 Inhaler + Insulin Aspart in combination with a basal insulin is a phase 3 stage product being developed by MannKind Corp for Type 1 Diabetes Mellitus. The current trial status is completed. This product is registered under clinical trial identifier NCT01445951. Target conditions include Type 1 Diabetes Mellitus.
What happened to similar drugs?
20 of 20 similar drugs in Type 1 Diabetes Mellitus were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01445951 | Phase 3 | Completed |
Competing Products
20 competing products in Type 1 Diabetes Mellitus